Summit Therapeutics Inc (NAS:SMMT)
$ 20.23 -0.53 (-2.55%) Market Cap: 14.92 Bil Enterprise Value: 14.75 Bil PE Ratio: 0 PB Ratio: 34.29 GF Score: 30/100

Q1 2023 Summit Therapeutics Inc Earnings Call Transcript

May 11, 2023 / 01:00PM GMT
Release Date Price: $1.93 (-9.20%)
Operator

Good morning, and welcome to the Summit Therapeutics First Quarter 2023 Earnings and Update Call. (Operator Instructions) Please note that today's call is being recorded. (Operator Instructions)

At this time, I would like to introduce the call to Dave Gancarz, Senior Vice President of Stakeholder Relations, Business Development and Corporate Strategy. You may proceed.

Dave Gancarz
Summit Therapeutics Inc. - SVP of Stakeholder Relations, Business Development & Corporate Strategy

?

Good morning, and thank you for joining us. Our press release was issued earlier this morning and is available on the home page of our website. Today's call is being simultaneously webcast, and an archived replay will also be made available later today on our website www.smmttx.com.

On the call with me today is Bob Duggan, our Chairman of the Board and Co-Chief Executive Officer; Dr. Maky Zanganeh, our Co-Chief Executive Officer and President; Ankur Dhingra, our Chief Financial Officer as well as Dr.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot